CDKN2A and hepatocellular carcinoma: We examined whether this phenomenon would also occur in HCC patients by analysing CDKN2A methylation and expression in HCC patients from TCGA and GSE56588 cohorts (for which methylation and expression data are available: 205/224 patients).